On cough syrups, a long overdue prescription

📌 Summary:

• Centre has removed cough syrups from Schedule K of the Drugs Rules, 1945 (the list of medicines sellable without a prescription); all syrup-based medicines, including codeine-containing ones, now require a prescription
• Trigger: Oct 2025 deaths of 20+ children in Madhya Pradesh & Rajasthan after consuming locally procured cough syrups; Coldrif was found to contain diethylene glycol far above permissible limits; similar deaths occurred in Jammu in Dec 2019-Jan 2020
• India-made cough syrups have been tied to the deaths of 140+ children in Africa and Central Asia since 2022
• Root cause: Entry 13 of Schedule K exemptions allowed sale through channels with weaker oversight than licensed pharmacies, especially in villages with population under 1,000, fostering self-medication and fragmented accountability
• Editorial caution: the prescription mandate alone is insufficient given a Centre-State coordination deficit, weak quality control and inspection, and a rapidly expanding pharma sector that regulators struggle to monitor
• Solutions urged: rigorous enforcement, greater transparency in adverse-event reporting, and investment in rural healthcare so patients are not pushed toward unlicensed vendors; shift from crisis-management to a patient-safety-first regulatory culture

🎯 UPSC Relevance: GS2 - regulation of the pharmaceutical sector, health governance, and Centre-State coordination in public health.

📝 Prelims Facts:

• Schedule K of the Drugs Rules, 1945 lists medicines that may be sold without a prescription
• Diethylene glycol (DEG) - a toxic industrial solvent implicated in the contaminated syrups
• Coldrif was the brand implicated in the Madhya Pradesh deaths

🔑 Key Term: Schedule K - a schedule under the Drugs Rules, 1945 granting specified exemptions, including over-the-counter sale, to certain drug categories.